James P. Rizzi - Concepedia

Author

James P. Rizzi

Pfizer (United States)

Also Known As

J. P. RIZZI, J. RIZZI, James P Rizzi, James P. Rizzi, James Rizzi

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Array BioPharma (United States)University of Rochester Cellerant Therapeutics (United States)The University of Texas Southwestern Medical Center

About

James P. Rizzi is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.8K
2	Biochemistry	6	6	493
3	Natural Sciences	5	5	457
4	Engineering	2	2	163
5	Biomolecular Engineering	1	1	40

James P. Rizzi

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Targeting renal cell carcinoma with a HIF-2 antagonist Wenfang Chen, Haley Hill, Alana Christie, Nature UrologyGenitourinary CancerRenal Cell CarcinomaAnti-cancer AgentMedicine	2016	697
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models Hyejin Cho, Xinlin Du, James P. Rizzi, Nature UrologyOncologyHif-2α AntagonistGenitourinary CancerKidney Research	2016	441
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma Eli M. Wallace, James P. Rizzi, Guangzhou Han, Cancer Research	2016	310
Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins Jayashree Aiyar, Jane M. Withka, James P. Rizzi, Neuron BiochemistryMedicineNatural SciencesVenomicsNmr-derived Structures	1995	254
The Signature Sequence of Voltage-gated Potassium Channels Projects into the External Vestibule Jayashree Aiyar, James P. Rizzi, George A. Gutman, Journal of Biological Chemistry Protein AssemblyGygd MotifMolecular BiologyChemical BiologyHyperpolarization (Biology)	1996	128
Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (<i>S</i>)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1<i>H</i>-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385) Paul M. Wehn, James P. Rizzi, Darryl D. Dixon, Journal of Medicinal Chemistry	2018	108
Multiple Active Site Corrections for Docking and Virtual Screening Guy Vigers, James P. Rizzi Journal of Medicinal Chemistry EngineeringHit IdentificationMolecular BiologyCorrection MethodComputational Chemistry	2003	97
A stereospecific total synthesis of aklavinone Andrew S. Kende, James P. Rizzi Journal of the American Chemical Society AltmetricsMolecular SciencesEngineeringDonut IconInformation	1981	66
UK‐78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage‐gated potassium channel and inhibits human T cell activation Douglas C. Hanson, Angela Nguyen, Robert J. Mather, British Journal of Pharmacology	1999	64
Potent selective nonpeptidic inhibitors of human lung tryptase Laurence E. Burgess, Bradley J. Newhouse, Prabha N. Ibrahim, Proceedings of the National Academy of Sciences	1999	63

Page 1